According to the National Institutes of Health, aneurysmal subarachnoid hemorrhage has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities.
According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the U.S. wherein 30,000 people are diagnosed for SAH each year.
Among these cases, raptured cerebral aneurysms accounts for nearly 80% of the non-traumatic aneurysmal subarachnoid hemorrhage. Going forward, these numbers are expected to mount even further, and thereby prove to be boon for the players in the global market for aneurysmal subarachnoid hemorrhage.
Smoking, hypertension, history of intracranial aneurysms in immediate relatives, chronic alcohol use are some of the common causes of aneurysmal subarachnoid hemorrhage, while the symptoms include headache, facial or orbital pain, unilateral third nerve palsy, bilateral lower extremity weakness, and vision loss. With no absolute therapy available and severity of the implications, early detection of SAH is of utmost importance and hence, there are vast opportunities available for the players venturing in the aneurysmal subarachnoid hemorrhage market.
In addition to that, the NIH study reveals that aneurysmal subarachnoid hemorrhage is more prevalent in developed region of North America including the U.S. in comparison to Japan and China in Asia Pacific. With the presence of several key players in the healthcare sector in North America, the research and development pertaining to aneurysmal subarachnoid hemorrhage is expected to drive the global aneurysmal subarachnoid hemorrhage market for the same.
Global Aneurysmal Subarachnoid Hemorrhage Market: Overview
Aneurysmal subarachnoid hemorrhage is a type of stroke and accounts for almost 7% of all strokes. It is listed under medical emergency conditions and can cause severe disability or can be fatal as well. Subarachnoid hemorrhage is sudden bleeding into the subarachnoid space of the central nervous system that may occur due to head injury, rupture of cerebral aneurysm, and aneurysm in other blood vessels. The most significant cause of aneurysmal subarachnoid hemorrhage is trauma. Some other causes of this condition are migraine, intra-cerebral hemorrhage, meningitis, and cerebral venous sinus thrombosis. In addition, lifestyle factors, smoking, genetics, hypertension, and excessive alcohol consumption are also significant factors for subarachnoid hemorrhage.
The report is an all-important tool to understand the progression of the global aneurysmal subarachnoid hemorrhage market between 2017 and 2025. In this report, the various market forces and growth indicators are analyzed at length to present a clear picture of strengths, weakness, threats, and opportunities of the market until the end of the forecast period in 2025.
Global Aneurysmal Subarachnoid Hemorrhage Market: Market Segmentation
The global aneurysmal subarachnoid hemorrhage market is segmented on the basis of diagnostic test, therapy, and geography. By diagnostic test, CT scan and MRI are the components of this market. Lumber puncture is mandatory in cases where imaging shows indefinite results. Xanthochromia is another diagnostic test that helps in the detection of aneurysmal subarachnoid hemorrhage. Cerebral angiography and transcranial Doppler ultrasound are also used for detecting aneurysmal subarachnoid hemorrhage.
The regional segments of the global aneurysm subarachnoid hemorrhage market are North America, Asia Pacific, Europe, and Rest of the World. As per an article published by Elsevier in 2014, countries such as Japan and Finland have high incidence rates of aneurysmal subarachnoid hemorrhage.
GET TABLE OF CONTENT OF THE REPORT
Global Aneurysmal Subarachnoid Hemorrhage Market: Drug Acceptance
In May 2013, Arbor Pharmaceuticals received FDA approval for Nymalize containing nimodipine for patients with subarachnoid hemorrhage. Currently, Arbor Pharmaceuticals possess the commercial rights of Nymalize solely in the US.
The primary treatment for aneurysmal subarachnoid hemorrhage involves stabilizing the patient by repairing the cause of bleeding with the help of vasospasms such as calcium channel blockers such as nimodipine. Anti-anxiety medications and pain killers, when administered, helps relieve headaches and pressure in the skull. Phenyton is used to treat or prevent the occurrence of seizures.
The treatment also focuses on alleviating symptoms and preventing complications such as permanent brain damage. Surgery is advised in cases where removal of large volume of blood is required to alleviate pressure on the brain. Aneurysm clipping, endovascular coiling, and craniotomy are some of the surgical procedures carried out for aneurysmal subarachnoid hemorrhage. Endovascular coiling involves placing coils in the aneurysm and stents in the blood vessel in order to lessen risk of further bleeding.
Companies and Institutions Mentioned in the Report
Some of the leading companies in the global aneurysmal subarachnoid market are Arbor Pharmaceuticals, Edge Therapeutics Inc., and Actelion Ltd. Key institutions that contribute to the global aneurysmal subarachnoid hemorrhage market are Chinese University of Hong Kong, Utrecht University, University of Miami, University of Cambridge, and the University of Calgary among others.
GET DISCOUNT ON THE LATEST REPORT
TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.
5-Point Growth Formula
The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.
The 5-point growth formula includes the following points:
- Current and Future Threats
- Accurate Trend Analysis
- Regional Assessment
- Industrial Analogy
- COVID-19 Impact
Current and Future Threats
Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.
Accurate Trend Analysis
Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.
Regional Assessment
Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.
Industrial Analogy
The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.
COVID-19 Impact
The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.
The reports offer answers to the top 7 questions that revolve around the growth of the market
- What are the diverse growth parameters influencing the market?
- Which regions will contribute largely to the growth of the market
- What are the recent innovations and technological advancements in the market?
- What are the emerging trends across the market?
- How has COVID-19 affected the market?
- What will be the post-pandemic scenario of the market?
- What are the major threats that will dent the growth prospects of the market?
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Contact:
Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site: https://www.tmrresearch.com/